1. Search Result
Search Result
Results for "

18:0 PI

" in MedChemExpress (MCE) Product Catalog:

11

Inhibitors & Agonists

1

Screening Libraries

3

Biochemical Assay Reagents

1

Natural
Products

1

Isotope-Labeled Compounds

6

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-100355

    C18-Ceramide

    Endogenous Metabolite Neurological Disease Cancer
    C18-Ceramide (d18:1/18:0) is a bioactive molecule with multiple functions in cells, not a traditional agonist or inhibitor targeting a single site. It can act on multiple cellular targets, such as proteins related to endoplasmic reticulum stress (e.g., ATF-4, XBP-1, CHOP), proteins in the PI3K/AKT signaling pathway, and SNARE complex proteins. It exerts activities like inducing cell death, promoting autophagy, and regulating exocytosis through mechanisms such as activating endoplasmic reticulum stress, inhibiting the PI3K/AKT signaling pathway, and affecting lipid raft - related functions. It can be used in research on the mechanism of neuronal injury in the field of neuroscience and in the treatment research of cancers such as glioma in the field of oncology .
    C18-Ceramide (d18:1/18:0)
  • HY-NP180

    Calcium Channel Metabolic Disease
    Progesterone/BSA is a conjugate of Progesterone (HY-N0437) and bovine serum albumin (BSA). Progesterone/BSA cannot penetrate the plasma membrane of human sperm, but still rapidly elevates intracellular free calcium and induces the acrosome reaction. Progesterone/BSA can also act as a probe to specifically bind to progesterone-binding proteins on the membrane of rat brain synaptosomes .
    Progesterone/BSA
  • HY-W020658S

    DSPI (18:0/18:0)-d6

    Isotope-Labeled Compounds Metabolic Disease
    18:0 PI-d6 (DSPI(18:0/18:0)-d6) is the deuterated form of 18:0 PI. 18:0 PI is a membrane-bound signaling molecule that is associated with almost all aspects of cell physiology, including cell growth, metabolism, proliferation, and survival .
    18:0 PI-d6
  • HY-175407

    Drug Derivative Others
    18:0-20:4 PI(3,4,5)P3 (sodium) is an analogue of phosphatidylinositol. Protein-binding to PtdIns-(3,4,5)-P3 is important for cytoskeletal rearrangements and membrane trafficking. PtdIns-(3,4,5)-P3 is resistant to cleavage by PI-specific PLC .
    18:0-20:4 PI(3,4,5)P3 sodium
  • HY-N16138

    DSPI (18:0/18:0)

    Others Metabolic Disease
    18:0 PI is a phosphoinositide. Phosphoinositides (PI) are similar to other phospholipids, but the head group is the cyclic myo-inositol.
    18:0 PI
  • HY-N16128

    PI(18:0/0:0)

    Others Metabolic Disease
    18:0 Lyso PI is a lysophosphatidylinositol.
    18:0 Lyso PI
  • HY-157645

    Biochemical Assay Reagents Others
    18:0-20:4 PI(4)P ammonium is a fatty acid.
    18:0-20:4 PI(4)P ammonium
  • HY-157648

    Biochemical Assay Reagents Others
    18:0-20:4 PI(3)P ammonium can be obtained by phosphorylation of the inositol ring of phosphatidylinositol and can be used in the preparation of liposomes.
    18:0-20:4 PI(3)P ammonium
  • HY-157652

    1-Stearoyl-2-arachidonoyl-sn-glycero-3-phospho-1′-myo-inositol-3′,4′,5′-trisphosphate ammonium

    Biochemical Assay Reagents
    18:0-20:4 PI(3,4,5)P3 (1-Stearoyl-2-arachidonoyl-sn-glycero-3-phospho-(1′-myo-inositol-3′,4′,5′-trisphosphate) (ammonium)) is a kind of biochemical reagent.
    18:0-20:4 PI(3,4,5)P3
  • HY-164662

    mTOR PI3K Cancer
    mTOR inhibitor-24 (comounp 9d) is a mTOR inhibitor, with IC50s of 0.34 nM (mTOR) and 324 nM (PI3K-α) respectively. mTOR inhibitor-24 inhibtis LNCaP cell proliferation (IC50: 180 nM) .
    mTOR inhibitor-24
  • HY-178984

    PI3K Epigenetic Reader Domain DNA/RNA Synthesis Akt c-Myc AMPK Cancer
    PI3Kα-IN-28 (Compound 23) is an efficient dual targeted PI3K/BRD4 inhibitor. PI3Kα-IN-28 can inhibit the proliferation of various cells, such as KYSE180 and KYSE450 cells. PI3Kα-IN-28 can concentration dependently inhibit migration and colony formation, induce G0/G1 phase arrest, significantly inhibit DNA synthesis, and significantly increase the proportion of senescent cells. PI3Kα-IN-28 can inhibit the expression of p-AKT and c-Myc and activate the AMPK-p27 pathway. PI3Kα-IN-28 can be used for research on cancers such as esophageal cancer .
    PI3Kα-IN-28

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: